Barrett's esophagus is an epithelial metaplasia associated with an increased risk for cancer, but its underlying mechanisms have been debated. Now Wang et al. (2011) suggest an intriguing explanation for this puzzle: a population of residual embryonic cells, lacking the transcription factor p63, migrates and repopulates a normal tissue damaged by inflammation or gastroesophageal reflux.
In Conjectures and Refutations, the great science philosopher Karl Popper asserts that the process of scientific discovery is based on several sequential steps: experimental evidence is consolidated into ''accepted dogmas,'' which need to be challenged for further conceptual advances to occur. Thus, thought-provoking papers, such as the one by Wang et al. (2011) in this issue of Cell, are always welcome. The paper focuses on two important points: the function of the transcription factor p63 in epithelial tissue and the processes involved in epithelial metaplasia. The latter point is of major interest for basic scientists studying development and cell fate commitment but also to clinicians interested in cancer-predisposing conditions.
Unlike its close cousin p53, p63 mainly functions in development. Approximately 10 years ago, two landmark papers revealed that this transcription factor is required for establishing stratified epithelia (i.e., epithelia with more than one layer of cells) and associated epithelial structures like hair follicles and mammary glands (Mills et al., 1999; Yang et al., 1999) . Two possible mechanisms have been proposed to explain the observed phenotype. The first is that p63 plays an essential role in maintaining self-renewing populations of epidermal stem cells, which give rise to stratified epithelia. Thus, in the absence of p63, the reservoir of these cells is exhausted and replaced by cells of a different lineage. The second explanation is that p63 is required for the switch from the differentiation program of simple, monolayer epithelia to that of stratified, multilayer epithelia. Thus, without p63, the transition between the two tissue types fails to occur.
A number of studies have provided convincing support for p63's role in maintaining stem cell populations of the epidermis, as well as of the thymic epithelial tissue (Crum and McKeon, 2010) . Underlying mechanisms for this maintenance include positive regulation of integrin receptors that are required for attachment and proliferation of basal cells and an antagonistic function with Notch signaling, a major pathway that promotes exit from the stem cell compartment and commitment to differentiation (Dotto, 2009) .
On the other hand, the evidence is equally compelling for p63's role in triggering the stratified epithelial lineage (Koster and Roop, 2007) . Inappropriate expression of p63 is sufficient to convert formation of a simple epithelium into stratified epithelial tissue (indeed, this is an important form of epithelial metaplasia, in addition to the one discussed below). Further, direct targets of p63 include genes linked intimately with the stratified differentiation program, such as keratin 14, which is expressed exclusively in basal cells of stratified epithelia. Despite much heated discussion on this topic, in our opinion the two functions of p63 are not mutually exclusive and may likely cooperate or be differentially applied depending on the developmental situation and context ( Figure 1A ).
The above mechanisms are especially important when one considers the role that p63 may have in epithelial metaplasia. Metaplasia, from the greek ''m3ta'' for ''after'' and ''plasma'' for ''something formed,'' is used in medicine to refer to the conversion of one tissue, after it is formed, into another. Most frequently, metaplasia involves neighboring tissues of the same origin (e.g., epithelial or mesenchymal), suggesting that the process involves either discrete genetic/epigenetic changes or a neighboring cell population encroaching on another population's territory (Herfs et al., 2009; Quinlan et al., 2007) . Nevertheless, the cells of origin for a metaplastic process, regardless of tissue type, remain elusive. Complicating matters are other processes that appear similar to metaplasia, such as the abnormal presence or persistence of ectopic tissues during development. Interestingly, even without metaplasia, zones of transition between simple and stratified epithelia are important sites of cancer development, raising the possibility that these sites contain reservoirs of cells with high transformation potential.
Barrett's esophagus is an intensely studied form of epithelial metaplasia associated with a high predisposition to cancer, specifically adenocarcinoma. The condition is likely triggered by gastroesophageal reflux and chronic inflammatory conditions and is defined as the replacement of a normally stratified squamous epithelium with a simple columnar epithelium. In many cases, but not all, cells of the intestinal secretory lineage (mucin-secreting goblet cells) emerge (Herfs et al., 2009; Quinlan et al., 2007) .
Substantial debate exists about the cells of origin of Barrett's esophagus and the underlying molecular mechanisms. Several theories have been proposed (Quinlan et al., 2007) , including the transdifferentiation of one committed cell type to another or the reprogramming of a progenitor or stem cell population toward a simple epithelial lineage rather than a stratified one ( Figure 1B) . Molecularly, two key players would be p63 and Cdx2, the latter being a transcription factor of the caudal-related homeobox family with an important role in intestinal epithelial development and differentiation. Consistent with this view, immunohistopathological and functional experimental studies have implicated the inappropriate expression of Cdx2 in Barrett's esophagus (Herfs et al., 2009; Quinlan et al., 2007) . Conversely, conditional Cdx2 deletion in the intestine results in squamous metaplasia (Gao et al., 2009) .
Expression of p63 is lost in Barrett's esophagus (Herfs et al., 2009; Quinlan et al., 2007) . Thus, one attractive hypothesis is that p63 normally functions as a negative regulator of Cdx2 expression. However, now Wang et al. report that Cdx2 is not upregulated in esophageal cells lacking p63, in spite of the columnar phenotype of these cells. The authors also note that increased expression of Cdx2 is not constantly observed in all forms of Barrett's esophagus. This may be a feature of the disease's later steps and/ or a reflection of different clinical classifications and heterogeneity of the condition (Quinlan et al., 2007) .
Another model for the development of Barrett's esophagus is the migration of cells to the site where metaplasia occurs, either sideways from the squamous/ columnar cell junction or upwards from glandular structures ( Figure 1B) . The latter are normally composed of a stratified epithelium in the upper one-third and a columnar epithelium in the lower twothirds. The findings of Wang et al. are in favor of a model of cell migration, but with an interesting twist. They propose that the cells of origin of Barrett's esophagus are a group of ''primitive'' epithelial cells, which are found in the developing esophagus and upper stomach region during embryogenesis but persist at the squamous-columnar cell junction in the adult esophagus ( Figure 1C) .
The authors carefully analyze and compare the embryonic tissue of wildtype mice versus mice lacking p63. Consistent with previous publications on this topic (Daniely et al., 2004; Yang et al., 1999) , they identify a population of p63-positive cells that, under normal conditions, invade the area occupied by p63-negative columnar cells, pushing them upwards and forcing them to eventually detach. While this is occurring, the p63-positive cells underneath the columnar cells give rise to a stratified epithelium. Intriguingly, the authors also observe this pattern of cell arrangement in the esophagus of a developing human fetus. This is an important observation, considering the well-known differences between mouse and human tissue organization and differentiation.
On the basis of these findings, Wang and colleagues argue that the epithelial metaplasia found in Barrett's esophagus is not the transformation of an already formed tissue into another tissue. Instead, they propose that the metaplasia derives from a reservoir of progenitor cells, which pre-exist in embryonic tissue and then repopulate or ''take over'' a damaged area when other cell populations have left. In further support of this hypothesis, the authors use inducible expression of a toxin transgene in stratified epithelial tissues. They find that loss of cells at the squamous/columnar junction, mimicking the one that occurs in Barrett's disease, results in the movement of primitive epithelial cells to the damaged area.
Many questions still remain about the new mechanism proposed by Wang and colleagues. First, it would have been interesting to assess the consequences of conditionally ablating p63 after birth. In addition, why are the p63-positive cells more sensitive than columnar primitive cells to the noxious effects resulting from the gastroesophageal reflux and chronic inflammatory condition, which likely trigger Barrett's esophagus (Herfs et al., 2009)? If correct, the model presented by Wang and colleagues would change the view of metaplasia, shifting the focus of attention from ''after'' to ''before the fact.'' For further ''conjectures and refutations,'' we refer to the authors' interesting discussion of the ''competitive or opportunistic cell replacement mechanism,'' which may be at the basis of Barrett's esophagus and other metaplastic conditions with increased cancer risk.
Transgenerational inheritance of epigenetic states allows organisms to pass on adaptive responses to the environment to their offspring. Seong et al. (2011) now reveal how stress-induced signaling through dATF-2 disrupts heterochromatin and leaves heritable marks that influence patterns of gene expression in subsequent generations.
The packing of DNA into condensed and inaccessible heterochromatin exerts a powerful influence on the genome, not only by suppressing transcription but also by governing proper segregation of chromosomes during cell division, silencing transposons and suppressing illegitimate recombination (Grewal and Elgin, 2007; Moazed, 2009 ). Heterochromatin nucleation involves the parallel actions of both the RNA interference (RNAi) machinery and sequence-specific DNA-binding proteins, and changes in the activity of either of these pathways provide a window of opportunity for chromatin states to change without corresponding alterations in DNA sequence. Such epigenetic changes, if passed to the next generation, may add an almost intangible layer of phenotypic variation at an organismal level. Although much attention has focused on how environmental stresses initiate ''a highly programmed sequence of events within the cell that serve to cushion the effects of the shock'' (McClintock, 1984) , we are only now beginning to learn about how stress modifies chromatin structure, and whether such stress-induced chromatin modification is heritable. In this issue, Seong et al. (2011) show that stressinduced phosphorylation of the transcription factor dATF-2 triggers the loss of heterochromatin structures at several regions of the genome in Drosophila, and that the disrupted heterochromatin state is transmitted to the next generation in a non-Mendelian fashion.
Previous work in the fission yeast Schizosaccharomyces pombe revealed that the RNAi pathway targets histone H3 lysine 9 (H3K9) methylation and the Swi6 protein (a homolog of animal HP1 proteins) to repetitive DNA sequences for heterochromatin assembly at the centromeres (Volpe et al., 2002) . However, in RNAi mutants, heterochromatin assembly can still occur at low efficiency. The transcription factors Atf1 and Pcr1, which belong to the activating transcription factor/cAMP response element-binding protein (ATF/ CREB) family of proteins, bind to their recognition sequences and cooperate with chromatin-modifying complexes such as SHREC (SNF2-and histone deacetylase-containing repressor complex) to nucleate and spread heterochromatin assembly independently at the centromeres (Jia et al., 2004) . Notably, Atf1 activity is regulated by stress-activated
